Artemether+Lumefantrine Suspension 180mg+1080mg/60ml with GMP

Product Details
Customization: Available
Application: Internal Medicine
Usage Mode: For oral administration
Still deciding? Get samples of US$ 0/Piece
Request Sample
Manufacturer/Factory, Trading Company

360° Virtual Tour

Diamond Member Since 2015

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Years of Export Experience
The export experience of the supplier is more than 10 years
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Importers and Exporters
The supplier has import and export rights
Management Certification
The supplier has quality management system certification, including:
ISO9001:2015 certificate
ISO45001:2018 certificate
ISO14001
to see all verified strength labels (20)
  • Artemether+Lumefantrine Suspension 180mg+1080mg/60ml with GMP
  • Artemether+Lumefantrine Suspension 180mg+1080mg/60ml with GMP
  • Artemether+Lumefantrine Suspension 180mg+1080mg/60ml with GMP
  • Artemether+Lumefantrine Suspension 180mg+1080mg/60ml with GMP
  • Artemether+Lumefantrine Suspension 180mg+1080mg/60ml with GMP
  • Artemether+Lumefantrine Suspension 180mg+1080mg/60ml with GMP
Find Similar Products

Basic Info.

Model NO.
AMC16008
Suitable for
Elderly, Children, Adult
State
Liquid
Shape
Oral Liquid
Type
Organic Chemicals
Pharmaceutical Technology
Chemical Synthesis
Standard
Bp, Cp
OEM/ODM
Support
Delivery Time
30~60 Days
Function
Malaria Infections
Transport Package
1 Bottle/Box
Specification
180mg+1080mg/60ml
Trademark
MEDIPHARM
Origin
China
HS Code
3003601000
Production Capacity
5000000 Per Month

Product Description

 
Artemether+Lumefantrine Suspension 180mg+1080mg/60ml with GMP

Artemether+Lumefantrine Suspension 180mg+1080mg/60ml

Indication:

The combination of artemether and lumefantrine is used to treat certain kinds of malaria infections. It works by killing the organisms that cause malaria.

Precautions & Warning:

  • Avoid in patients with prolongation of the QT interval or certain clinical conditions.
  • Avoid in patients with known disturbances of electrolyte balance.
  • Avoid in patients receiving medications that prolong the QT interval.

Contra-indications:

Avoid in patients with hypersensitivity to artemether, lumefantrine, or any excipients of Coartem Tablets.

Treatment:

No information on overdoses higher than recommended doses. Symptomatic and supportive therapy should be given in cases of suspected overdosage.

Teratagenicity:

Artemether-lumefantrine is assigned to pregnancy category C. Use during pregnancy only when benefit outweighs risk.

 

Artemether+Lumefantrine Suspension 180mg+1080mg/60ml with GMPArtemether+Lumefantrine Suspension 180mg+1080mg/60ml with GMPArtemether+Lumefantrine Suspension 180mg+1080mg/60ml with GMPArtemether+Lumefantrine Suspension 180mg+1080mg/60ml with GMPArtemether+Lumefantrine Suspension 180mg+1080mg/60ml with GMPArtemether+Lumefantrine Suspension 180mg+1080mg/60ml with GMP

More Products:

 
Artemether+Lumefantrine Suspension 180mg+1080mg/60ml with GMP
Artemether+Lumefantrine Suspension 180mg+1080mg/60ml with GMP
Artemether+Lumefantrine Suspension 180mg+1080mg/60ml with GMP
 
Artemether+Lumefantrine Suspension 180mg+1080mg/60ml with GMP
Artemether+Lumefantrine Suspension 180mg+1080mg/60ml with GMP
 
Artemether+Lumefantrine Suspension 180mg+1080mg/60ml with GMP

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier